Myelodysplastic/Myeloproliferative Neoplasm
generalA category of clonal hematopoietic disorders that have both myelodysplastic and myeloproliferative features at the time of initial presentation.
37
Centers
40
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
Top Centers for Myelodysplastic/Myeloproliferative Neoplasm(37)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 72.6 |
| 2 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 72.6 |
| 3 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 65.9 |
| 4 | NCI Comprehensive Active Research Program | 65.9 |
| 5 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 65.9 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 65.9 |
| 7 | NCI Comprehensive Active Research Program | 65.9 |
| 8 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 65.9 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 65.9 |
| 10 | Cancer Center at IllinoisUrbana, IL Active Research Program | 65.9 |
| 11 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 65.9 |
| 12 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 50.7 |
| 13 | NCI Comprehensive Active Research Program | 50.7 |
| 14 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 50.7 |
| 15 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 50.7 |
| 16 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 50.7 |
| 17 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 50.7 |
| 18 | NCI Comprehensive Active Research Program | 50.7 |
| 19 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 50.7 |
| 20 | NCI Clinical Active Research Program | 50.7 |
| 21 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 50.7 |
| 22 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 50.7 |
| 23 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 50.7 |
| 24 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 50.7 |
| 25 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 50.7 |
| 26 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 50.7 |
| 27 | Active Research Program | 50.7 |
| 28 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 34.9 |
| 29 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 34.9 |
| 30 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 34.9 |
| 31 | NCI Comprehensive | 34.9 |
| 32 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 34.9 |
| 33 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 34.9 |
| 34 | Cleveland Clinic Cancer CenterCleveland, OH | 34.9 |
| 35 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 34.9 |
| 36 | Princess Margaret Cancer CentreToronto, ON | 34.9 |
| 37 | BC CancerVancouver, BC | 34.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →